The global pain management software market is expected to exhibit strong growth, reaching USD 3.9 million by 2030. As per the report titled "Pain management software Market Size, Share & COVID-19 Impact Analysis, By Type (PVC, ABS Plastic and Others), By Application (Entertainment, Competition and Others), and Regional Forecasts, 2023-2030" observes that the market size in 2022 stood at USD 2.1 million and USD 3.9 million in 2030. The market is expected to exhibit a CAGR of 8.40% during the forecast period.
Yale New Haven Health System and IncludeHealth Collaborated to Enhance Treatment for Patients with MSK Issues
In December 2022, for the benefit of patients with MSK issues, Yale New Haven Health System collaborated with the digital musculoskeletal business IncludeHealth. By employing IncludeHealth's platform to deliver virtual physical therapy in patient's homes, the company will offer a hybrid treatment approach thanks to this agreement. This hybrid model, which is a first for the industry, will be helpful for a range of patient demographics, including those undergoing surgery, those with chronic pain, and those receiving outpatient physical therapy, according to both companies.
Growing Prevalence of Chronic Diseases to Drive Market Growth
The market is expanding due to a rise in the demand for pain management software brought on by chronic diseases. Patients with chronic illnesses like cancer and heart attacks frequently experience intolerable pain, which increases the need for pain-relieving medications and treatments. Chronic illnesses last for a long time and worsen the patient's health. According to a Brazilian Journal of Nephrology study, almost 60% of patients with chronic renal disease reported experiencing the pain of any degree that necessitated painkillers. The US National Library of Medicine reported that 133 million Americans, or about 45% of the population, had at least one chronic illness. Additionally, it is claimed that chronic diseases like diabetes, cancer, chronic obstructive pulmonary disease, and cancer account for more than two-thirds of all fatalities. The rise in chronic diseases is driving the market for pain management software.
Product Recall Could Limit the Market Growth
In order to provide vital fluids, neurostimulators, and ablation, including high-risk drugs, pain management software is used. Patients may suffer severe injury and possibly pass away due to mistakes made using this software. Approximately 1.5 million patients every year experience prescription errors, spending $8,750 per potential adverse drug event, according to the Institute of Medicine (US) (PADE). Software providers are very concerned about the recall of these items owing to safety and efficacy issues because it affects the sales of pain management software. Providers are forced to compensate for serious injuries caused by accidents and replace defective devices with updated models as a result of these recall campaigns. Therefore, product recalls impacting the market growth for pain management software.
Major Players Develop Acquisition Plans to Boost Brand Image
The leading businesses in the pain management software market plan acquisitions to improve their brand recognition globally. For instance, in September 2018, GeoPain, a pain tracking app from MoxyTech, uses a 3-D body image to show users where and how much pain is being experienced.
List of Key Players Profiled in the Report
Yale New Haven Health System and IncludeHealth Collaborated to Enhance Treatment for Patients with MSK Issues
In December 2022, for the benefit of patients with MSK issues, Yale New Haven Health System collaborated with the digital musculoskeletal business IncludeHealth. By employing IncludeHealth's platform to deliver virtual physical therapy in patient's homes, the company will offer a hybrid treatment approach thanks to this agreement. This hybrid model, which is a first for the industry, will be helpful for a range of patient demographics, including those undergoing surgery, those with chronic pain, and those receiving outpatient physical therapy, according to both companies.
Growing Prevalence of Chronic Diseases to Drive Market Growth
The market is expanding due to a rise in the demand for pain management software brought on by chronic diseases. Patients with chronic illnesses like cancer and heart attacks frequently experience intolerable pain, which increases the need for pain-relieving medications and treatments. Chronic illnesses last for a long time and worsen the patient's health. According to a Brazilian Journal of Nephrology study, almost 60% of patients with chronic renal disease reported experiencing the pain of any degree that necessitated painkillers. The US National Library of Medicine reported that 133 million Americans, or about 45% of the population, had at least one chronic illness. Additionally, it is claimed that chronic diseases like diabetes, cancer, chronic obstructive pulmonary disease, and cancer account for more than two-thirds of all fatalities. The rise in chronic diseases is driving the market for pain management software.
Product Recall Could Limit the Market Growth
In order to provide vital fluids, neurostimulators, and ablation, including high-risk drugs, pain management software is used. Patients may suffer severe injury and possibly pass away due to mistakes made using this software. Approximately 1.5 million patients every year experience prescription errors, spending $8,750 per potential adverse drug event, according to the Institute of Medicine (US) (PADE). Software providers are very concerned about the recall of these items owing to safety and efficacy issues because it affects the sales of pain management software. Providers are forced to compensate for serious injuries caused by accidents and replace defective devices with updated models as a result of these recall campaigns. Therefore, product recalls impacting the market growth for pain management software.
Major Players Develop Acquisition Plans to Boost Brand Image
The leading businesses in the pain management software market plan acquisitions to improve their brand recognition globally. For instance, in September 2018, GeoPain, a pain tracking app from MoxyTech, uses a 3-D body image to show users where and how much pain is being experienced.
List of Key Players Profiled in the Report
- B. Braun Melsungen AG
- Baxter
- Boston Scientific Corp.
- Enovis
- Medtronic
- ICU Medical, Inc.
- Abbott
- Stryker
- Nevro Corp.
- Omron Healthcare, Inc.
- Stimwave LLC
Further Report Findings
- The market in North Anerica is expected to gain a huge portion of the global pain management software market share in the coming years because of the good healthcare infrastructure, which makes it simple to get cutting-edge pain management technologies.
- Additionally, the expansion of the market is being aided by rising government initiatives and a carefully thought-out reimbursement structure in this region.
- In the Asia Pacific, the growth in this region is primarily driven by a growing number of hospitals and speciality clinics are using technology quickly and enhancing their health infrastructure.
Attributes | Details |
Study Period | 2016-2030 |
Base Year | 2022 |
Estimated Year | 2023 |
Forecast Period | 2023-2030 |
Historical Period | 2016-2021 |
Unit | Revenue (USD Million) and Volume (Kilo Tons) |
Segmentation | By Type, By Application, By Mode of Purchase, and By Geography |
By Type |
|
By Application |
|
By Mode of Purchase |
|
By Region |
|